MX2009010174A - Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos. - Google Patents
Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos.Info
- Publication number
- MX2009010174A MX2009010174A MX2009010174A MX2009010174A MX2009010174A MX 2009010174 A MX2009010174 A MX 2009010174A MX 2009010174 A MX2009010174 A MX 2009010174A MX 2009010174 A MX2009010174 A MX 2009010174A MX 2009010174 A MX2009010174 A MX 2009010174A
- Authority
- MX
- Mexico
- Prior art keywords
- ester
- methods
- azaadamantane
- carbamate derivatives
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a compuestos que son derivados de azaadamantano éster y carbamato substituidos, composiciones que comprenden dichos compuestos, y métodos para utilizar dichos compuestos y composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89674507P | 2007-03-23 | 2007-03-23 | |
PCT/US2008/057641 WO2008118742A1 (en) | 2007-03-23 | 2008-03-20 | Azaadamantane ester and carbamate derivatives and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009010174A true MX2009010174A (es) | 2009-10-12 |
Family
ID=39788934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009010174A MX2009010174A (es) | 2007-03-23 | 2008-03-20 | Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos. |
Country Status (10)
Country | Link |
---|---|
US (2) | US8163916B2 (es) |
EP (1) | EP2129672B1 (es) |
JP (2) | JP5566698B2 (es) |
CN (2) | CN103145711A (es) |
AT (1) | ATE509931T1 (es) |
CA (1) | CA2679870A1 (es) |
ES (1) | ES2363998T3 (es) |
HK (1) | HK1133642A1 (es) |
MX (1) | MX2009010174A (es) |
WO (1) | WO2008118742A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8314119B2 (en) | 2006-11-06 | 2012-11-20 | Abbvie Inc. | Azaadamantane derivatives and methods of use |
NZ597511A (en) * | 2009-06-19 | 2014-01-31 | Abbvie Inc | Diazahomoadamantane derivatives and methods of use thereof |
KR101778547B1 (ko) * | 2010-05-25 | 2017-09-15 | 시므라이즈 아게 | 항-셀룰라이트 성분으로서의 사이클로헥실 카바메이트 화합물 |
EP2389922A1 (en) * | 2010-05-25 | 2011-11-30 | Symrise AG | Cyclohexyl carbamate compounds as anti-ageing actives |
WO2010122178A2 (en) * | 2010-05-25 | 2010-10-28 | Symrise Gmbh & Co. Kg | Cyclohexyl carbamate compounds as skin and/or hair lightening actives |
EP2619205B1 (en) | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
WO2014164682A1 (en) | 2013-03-12 | 2014-10-09 | Abbvie Inc. | Azaadamantane formate ester and process preparing azaadamantane derivatives |
WO2016007630A1 (en) * | 2014-07-11 | 2016-01-14 | Alpharmagen, Llc | Quinuclidine compounds for modulating alpha7 -nicotinic acetylcholine receptor activity |
EP3623371A1 (en) | 2014-12-16 | 2020-03-18 | Axovant Sciences GmbH | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
RU2017145964A (ru) | 2015-06-10 | 2019-07-10 | Аксовант Сайенсиз Гмбх | Аминобензизоксазольные соединения в качестве агонистов α7-никотиновых ацетилхолиновых рецепторов |
WO2017027600A1 (en) | 2015-08-12 | 2017-02-16 | Forum Pharmaceuticals, Inc. | GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8523211D0 (en) | 1985-09-19 | 1985-10-23 | Beecham Group Plc | Compounds |
NL8701682A (nl) | 1986-07-30 | 1988-02-16 | Sandoz Ag | Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten. |
ES2080727T3 (es) * | 1988-02-23 | 1996-02-16 | Merrell Pharma Inc | Uso de quinolizina y derivados de quinolizinona en la fabricacion de medicamentos. |
US5140023A (en) * | 1990-04-27 | 1992-08-18 | G. D. Searle & Co. | Azatetracycle compounds |
US5260303A (en) | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
US5280028A (en) | 1992-06-24 | 1994-01-18 | G. D. Searle & Co. | Benzimidazole compounds |
US5521193A (en) * | 1992-06-24 | 1996-05-28 | G. D. Searle & Co. | Benzimidazole compounds |
US5434151A (en) | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5840903A (en) * | 1992-07-27 | 1998-11-24 | G. D. Searle & Co. | 4-aminomethyl-1-azaadamantane derived benzamides |
US5399562A (en) | 1994-02-04 | 1995-03-21 | G. D. Searle & Co. | Indolones useful as serotonergic agents |
WO1995021820A1 (fr) * | 1994-02-10 | 1995-08-17 | Yamanouchi Pharmaceutical Co., Ltd. | Nouveau derive du carbamate et composition correspondante |
EP1125922A1 (en) * | 1998-11-02 | 2001-08-22 | Welfide Corporation | Pyrrolidine compounds and medicinal utilization thereof |
MY137020A (en) | 2000-04-27 | 2008-12-31 | Abbott Lab | Diazabicyclic central nervous system active agents |
JP4616971B2 (ja) * | 2000-07-18 | 2011-01-19 | 田辺三菱製薬株式会社 | 1−アザビシクロアルカン化合物およびその医薬用途 |
RU2441868C2 (ru) * | 2007-02-09 | 2012-02-10 | Астеллас Фарма Инк. | Аза-кольцевое соединение с внутренним мостиком |
-
2008
- 2008-03-20 AT AT08732552T patent/ATE509931T1/de not_active IP Right Cessation
- 2008-03-20 WO PCT/US2008/057641 patent/WO2008118742A1/en active Application Filing
- 2008-03-20 CN CN2013100426086A patent/CN103145711A/zh active Pending
- 2008-03-20 EP EP08732552A patent/EP2129672B1/en active Active
- 2008-03-20 CN CN200880009459A patent/CN101641355A/zh active Pending
- 2008-03-20 ES ES08732552T patent/ES2363998T3/es active Active
- 2008-03-20 JP JP2009554736A patent/JP5566698B2/ja not_active Expired - Fee Related
- 2008-03-20 MX MX2009010174A patent/MX2009010174A/es active IP Right Grant
- 2008-03-20 US US12/052,036 patent/US8163916B2/en not_active Expired - Fee Related
- 2008-03-20 CA CA002679870A patent/CA2679870A1/en not_active Abandoned
-
2010
- 2010-01-22 HK HK10100761.5A patent/HK1133642A1/xx not_active IP Right Cessation
-
2012
- 2012-03-23 US US13/427,999 patent/US20120190704A1/en not_active Abandoned
-
2014
- 2014-06-17 JP JP2014124038A patent/JP2014205695A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2008118742A1 (en) | 2008-10-02 |
JP2014205695A (ja) | 2014-10-30 |
JP5566698B2 (ja) | 2014-08-06 |
US20120190704A1 (en) | 2012-07-26 |
US20080255178A1 (en) | 2008-10-16 |
CA2679870A1 (en) | 2008-10-02 |
EP2129672A4 (en) | 2009-12-09 |
CN103145711A (zh) | 2013-06-12 |
ES2363998T3 (es) | 2011-08-22 |
HK1133642A1 (en) | 2010-04-01 |
EP2129672A1 (en) | 2009-12-09 |
EP2129672B1 (en) | 2011-05-18 |
CN101641355A (zh) | 2010-02-03 |
ATE509931T1 (de) | 2011-06-15 |
JP2010522201A (ja) | 2010-07-01 |
US8163916B2 (en) | 2012-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1133642A1 (en) | Azaadamantane ester and carbamate derivatives and methods of use thereof | |
JOP20180102A1 (ar) | مركب صيدلاني | |
MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
MX2012007507A (es) | Compuestos de heteroarilo y usos de los mismos. | |
MY181898A (en) | Heterocyclic compounds and uses thereof | |
MY153915A (en) | Organic compounds | |
NO20090596L (no) | Antivirale fosfinatforbindelser | |
TW200806280A (en) | Pharmaceutical compositions | |
JO2778B1 (en) | Certain vehicles, installations and methods | |
WO2011032169A3 (en) | Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same | |
WO2009156484A3 (en) | Organic compounds | |
IN2014DN09346A (es) | ||
MY148253A (en) | Azaadamantane derivatives and methods of use | |
WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
MY152692A (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
MX2009004862A (es) | Estabilizacion de vacunas por liofilizacion. | |
TW200634023A (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
HK1142608A1 (en) | 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5- | |
WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
EP2557919A4 (en) | STABILIZED FORMULATIONS OF STATIN | |
UA106889C2 (uk) | Похідні n1-ацил-5-фторпіримідинону | |
MX2009010176A (es) | Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos. | |
TN2009000510A1 (en) | Extended release formulation of nevirapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |